⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARVN News
Arvinas, Inc
Form 8-K
sec.gov
ARVN
Entact Bio Appoints John G. Houston, Ph.D., to its Board of Directors
globenewswire.com
ARVN
BMY
Form 8-K
sec.gov
ARVN
Form 8-K
sec.gov
ARVN
Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant)
prnewswire.com
RIGL
ARVN
PFE
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
globenewswire.com
ARVN
Form 8-K
sec.gov
ARVN
Arvinas to Present at Jefferies Global Healthcare Conference
globenewswire.com
ARVN
Arvinas Employees Give Back During Company-wide Impact Day
globenewswire.com
ARVN
CapeHaven Completes First Close of Funding and Initiates Operations to Encourage Yale’s Biotech Spinouts
globenewswire.com
MRK
ARVN